Two large novel alpha-globin gene cluster deletions causing alpha(0)-thalassemia in two Chinese families.

• We have characterized two novel 16p13.3 deletions, with a deletion size of 108 Kb and ∼336 Kb, respectively. • The 108-kb deletion arose de novo, the precise 5′ and 3′ breakpoints were identified comprehensively using of molecular methods. • Except for a haematological phenotype of α0-thalassemia, no developmental and neurological abnormalities were noticed in the deletion carriers. Monosomy of terminal 16p13.3 is a relatively common subtelomeric abnormality, most affected individuals presented α-thalassemia, some also have mental retardation, developmental abnormalities and/or speech delay and facial dysmorphism, which is termed ATR-16 syndrome. Here, we reported two novel 16p13.3 deletions involving the α-globin gene cluster and multispecies conserved sequences (MCSs), causing only a phenotype of α-thalassemia. Samples were collected from members of the two families and were subjected to haematological and comprehensive genetic analysis. The novel 108 Kb deletion in family A extends from the non-protein coding RNA gene (WASIR2) to the NPRL3 gene , removing MCS-R1 to R3. This deletion should arise de novo because it wasn't detected in both parents. The novel 336 Kb deletion in family B should extend from telomere to ∼ chr16:336000, removing the entire α-globin gene cluster. Carriers of these two deletions presented with microcytosis and hypochromic red cells, in accordance with a phenotype of α0-thalassemia carrier. Our study increases the mutation spectrum of α-thalassemia. MCSs deletion should be considered in clinical practice of thalassemia screening and diagnosis. [ABSTRACT FROM AUTHOR]